Surface-catalyzed amyloid fibril formation

被引:216
作者
Zhu, M
Souillac, PO
Ionescu-Zanetti, C
Carter, SA
Fink, AL
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[2] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA
关键词
D O I
10.1074/jbc.M207225200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Light chain (or AL) amyloidosis is characterized by the pathological deposition of insoluble fibrils of immunoglobulin light chain fragments in various tissues, walls of blood vessels, and basement membranes. In the present investigation, the in vitro assembly of a recombinant amyloidogenic light chain variable domain, SMA, on various surfaces was monitored using atomic force microscopy. SAU formed fibrils on native mica at pH 5.0, conditions under which predominantly amorphous aggregates form in solution. Fibril formation was accelerated significantly on surfaces compared with solution; for example, fibrils grew on surfaces at significantly faster rates and at much lower concentrations than in solution. No fibrils were observed on hydrophobic or positively charged surfaces or at pH >7.0. Two novel types. of fibril growth were observed on the surface: bidirectional linear assembly of oligomeric units, and linear growth from preformed amorphous cores. In addition to catalyzing the rate of fibrillation, the mechanism of fibril formation on the surfaces was significantly different from in solution, but it may be more physiologically relevant because in vivo the deposits are associated with surfaces.
引用
收藏
页码:50914 / 50922
页数:9
相关论文
共 38 条
[1]   In-situ atomic force microscopy study of β-amyloid fibrillization [J].
Blackley, HKL ;
Sanders, GHW ;
Davies, MC ;
Roberts, CJ ;
Tendler, SJB ;
Wilkinson, MJ .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 298 (05) :833-840
[2]   Nonamyloidotic monoclonal immunoglobulin deposition disease - Light-chain, heavy-chain, and light- and heavy-chain deposition diseases [J].
Buxbaum, J ;
Gallo, G .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) :1235-+
[3]   MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE [J].
BUXBAUM, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :323-346
[4]  
Ding TT, 1999, METHOD ENZYMOL, V309, P510
[5]  
Gallo G, 1996, AM J PATHOL, V148, P1397
[6]   Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? [J].
Goldberg, MS ;
Lansbury, PT .
NATURE CELL BIOLOGY, 2000, 2 (07) :E115-E119
[7]   Watching amyloid fibrils grow by time-lapse atomic force microscopy [J].
Goldsbury, C ;
Kistler, J ;
Aebi, U ;
Arvinte, T ;
Cooper, GJS .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (01) :33-39
[8]   Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide [J].
Huang, THJ ;
Yang, DS ;
Plaskos, NP ;
Go, S ;
Yip, CM ;
Fraser, PE ;
Chakrabartty, A .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 297 (01) :73-87
[9]   Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy [J].
Ionescu-Zanetti, C ;
Khurana, R ;
Gillespie, JR ;
Petrick, JS ;
Trabachino, LC ;
Minert, LJ ;
Carter, SA ;
Fink, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13175-13179
[10]   α-synuclein membrane interactions and lipid specificity [J].
Jo, EJ ;
McLaurin, J ;
Yip, CM ;
St George-Hyslop, P ;
Fraser, PE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34328-34334